Bio-XL Ltd

Bio-XL Ltd is a pioneering pharmaceutical manufacturing company dedicated to transforming innovative technologies into life-changing pharmaceutical drugs. Bio-XL is committed to developing biomedical solutions for undertreated diseases, striving to enhance patient outcomes and improve healthcare worldwide.

Bio-XL’s current portfolio includes CancerPredict, an improved screening program for breast cancer designed to predict cancer development in the future, and CeaseCancer, a universal anti-cancer drug aimed at replacing or reducing chemotherapy doses to minimize adverse effects, with a focus on breast cancer (TNBC) and pancreatic cancer. Bio-XL holds a worldwide license from Sheba and Cedar-Sinai Medical Centers, enabling the company to bring these cutting-edge solutions to a global market.

Located at 15 Nahal Snir st., 3rd floor, Yavne, Israel 8122451, IL, Bio-XL is poised for continued growth and innovation in the pharmaceutical industry. Bio-XL is dedicated to advancing medical science and improving the lives of patients through its groundbreaking research and development efforts. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further highlight Bio-XL’s contributions and capabilities.